MDSAP utilizes GHTF SG3 N19-Nonconformity Grading System for Regulatory Purposes, consisting of a two-step approach that leads to
the calculation of a final grade for each nonconformity: Step 1 - A grading matrix that provides an initial grade and Step 2 - escalation rules to determine a final grade of 1 to 5.
In Step 1, the matrix divides the clauses of ISO 13485:2016 into two categories:
QMS clauses that have an
indirect impact on the device's safety and performance (Clauses 4.1 through 6.3).
QMS clauses that have a
direct impact on the device's safety and performance (Clauses 6.4 through 8.5.3).
A nonconformity would be graded a 1 or a 3, based on its potential to affect safety or performance whereas a repeat nonconformity would be graded 2 or 4 if it had been previously identified
In Step 2, the Step 1 score may be increased by +1 for the absence of a documented process and by +1 for the release of a nonconforming product.
The final nonconformity grade will be between 1 and 6. However, grades of 6 will be listed as 5. A grade of 4 or above is determined to carry a high enough risk that intervention is required.
Hope it helps.
------------------------------
Jo Huang RAC
Sr. Regulatory Affairs Specialist
Athens TX
United States
------------------------------
Original Message:
Sent: 13-Jan-2020 18:45
From: Anonymous Member
Subject: QMS Risk Assessment
This message was posted by a user wishing to remain anonymous
Does anyone have an acceptance criteria scale for QMS risk assessment that is used for MDSAP requirements?
For example, in your NCR/CAPA process, how is QMS risk assessment defined? What are the criteria? High, Medium, Low. How is this assessment conducted?